291 related articles for article (PubMed ID: 30539028)
1. Mediators of Inflammation - A Potential Source of Biomarkers in Oral Squamous Cell Carcinoma.
Tampa M; Mitran MI; Mitran CI; Sarbu MI; Matei C; Nicolae I; Caruntu A; Tocut SM; Popa MI; Caruntu C; Georgescu SR
J Immunol Res; 2018; 2018():1061780. PubMed ID: 30539028
[TBL] [Abstract][Full Text] [Related]
2. Identification of inflammatory mediators associated with metastasis of oral squamous cell carcinoma in experimental and clinical studies: systematic review.
Elhousiny M; Miller K; Ariyawadana A; Nimmo A
Clin Exp Metastasis; 2019 Dec; 36(6):481-492. PubMed ID: 31559586
[TBL] [Abstract][Full Text] [Related]
3. Salivary auto-antibodies as noninvasive diagnostic markers of oral cavity squamous cell carcinoma.
Wu CC; Chang YT; Chang KP; Liu YL; Liu HP; Lee IL; Yu JS; Chiang WF
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1569-78. PubMed ID: 24859869
[TBL] [Abstract][Full Text] [Related]
4. [Value of squamous cell epithelial-associated (SCC-) antigens in early diagnosis of oral carcinoma].
Zöller J; Mende U; Fiehn W
ZWR; 1990 Dec; 99(12):981-2, 984-5. PubMed ID: 2100453
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
6. Neutrophils and oral squamous cell carcinoma: lessons learned and future directions.
Magalhaes MA; Glogauer JE; Glogauer M
J Leukoc Biol; 2014 Nov; 96(5):695-702. PubMed ID: 25145471
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma.
Eckert AW; Wickenhauser C; Salins PC; Kappler M; Bukur J; Seliger B
J Transl Med; 2016 Apr; 14():85. PubMed ID: 27044404
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma.
Lee LT; Wong YK; Hsiao HY; Wang YW; Chan MY; Chang KW
Int J Oral Maxillofac Surg; 2018 Jun; 47(6):699-707. PubMed ID: 29174861
[TBL] [Abstract][Full Text] [Related]
9. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
10. Oral squamous cell carcinoma: diagnostic markers and prognostic indicators.
Lauritano D; Lucchese A; Contaldo M; Serpico R; Lo Muzio L; Biolcati F; Carinci F
J Biol Regul Homeost Agents; 2016; 30(2 Suppl 1):169-76. PubMed ID: 27469565
[TBL] [Abstract][Full Text] [Related]
11. Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics.
Irimie AI; Braicu C; Cojocneanu-Petric R; Berindan-Neagoe I; Campian RS
Acta Odontol Scand; 2015 Apr; 73(3):161-8. PubMed ID: 25598447
[TBL] [Abstract][Full Text] [Related]
12. Genetic and Epigenetic Biomarkers of Molecular Alterations in Oral Carcinogenesis.
Dumache R; Rogobete AF; Andreescu N; Puiu M
Clin Lab; 2015; 61(10):1373-81. PubMed ID: 26642697
[TBL] [Abstract][Full Text] [Related]
13. Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma.
Sasahira T; Kirita T
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30115834
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 beta in unstimulated whole saliva is a potential biomarker for oral squamous cell carcinoma.
Kamatani T; Shiogama S; Yoshihama Y; Kondo S; Shirota T; Shintani S
Cytokine; 2013 Nov; 64(2):497-502. PubMed ID: 24063998
[TBL] [Abstract][Full Text] [Related]
15. Inflammation in the assessment of salivary cytokines in oral squamous cell carcinoma diagnosis.
Özçaka Ö; Epstein JB; Güneri P
Oral Oncol; 2017 Aug; 71():96-98. PubMed ID: 28688699
[No Abstract] [Full Text] [Related]
16. Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis.
Bugshan A; Farooq I
F1000Res; 2020; 9():229. PubMed ID: 32399208
[TBL] [Abstract][Full Text] [Related]
17. Potential biomarkers for oral squamous cell carcinoma: proteomics discovery and clinical validation.
Ni YH; Ding L; Hu QG; Hua ZC
Proteomics Clin Appl; 2015 Feb; 9(1-2):86-97. PubMed ID: 25431113
[TBL] [Abstract][Full Text] [Related]
18. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
[TBL] [Abstract][Full Text] [Related]
19. EGF in saliva and tumor samples of oral squamous cell carcinoma.
Bernardes VF; Gleber-Netto FO; Sousa SF; Silva TA; Abreu MH; Aguiar MC
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):528-33. PubMed ID: 21436680
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2--An Imperative Prognostic Biomarker in Oral Squamous Cell Carcinoma--An Immunohistochemical Study.
Byatnal AA; Byatnal A; Sen S; Guddattu V; Solomon MC
Pathol Oncol Res; 2015 Sep; 21(4):1123-31. PubMed ID: 25962348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
